Navigation Links
Frost & Sullivan Hosts Presentation on MicroRNAs: From Stem Cells and Cancer to Diagnostics and Therapeutics
Date:3/30/2009

A Complimentary Webinar

MOUNTAIN VIEW, Calif., March 30 /PRNewswire/ --

     -  TOPIC:      The state of the microRNA market and the molecule's
                    current and potential impact on drug discovery, molecular
                    diagnostics, and personalized therapeutics.
     -  WHEN:       Tuesday, March 31, 2009
     -  TIME:       3 pm EDT
     -  LOCATION:   Online with free registration
     -  HOST:       Christi Bird, Senior Research Analyst, Healthcare
                    practice, Frost & Sullivan
     -  GUESTS:
          -  Dr. George Calin, Associate Professor, The University of Texas
             M. D. Anderson Cancer Center
          -  Alex Amiet, Senior Product Manager, Thermo Fisher Scientific


     -  This panel discussion will benefit life science research tools
        manufacturers, services providers, diagnostic companies,
        biotechnology companies, pharmaceutical companies, academic
        researchers and venture capitalists.  The outlook for the microRNA
        market will be presented from a three-pronged perspective of an
        industry analyst with knowledge of the market, a microRNA expert
        from academia, and a provider of microRNA tools and services.

Supporting Quote

"The rapid discoveries linking microRNAs to various diseases have propelled the microRNA field and tools market in recent years. Moving forward, however, the microRNA field requires more innovative studies of larger scope to make good on its lofty promise," says Bird of Frost & Sullivan.

Supporting Resources

To participate, please email Stephanie Ochoa, stephanie.ochoa@frost.com, with the following information: your full name, title, company name, company telephone number, company email address, city, state and country. Upon receipt of the above information, a registration link will be emailed to you. You may also register to receive a recorded version of the briefing at anytime by submitting the aforementioned contact details.

Frost & Sullivan's Drug Discovery practice: www.frost.com/drugdiscovery

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

    Contact:
    Stephanie Ochoa
    Frost & Sullivan
    +1.210.247.2421
    stephanie.ochoa@frost.com

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Frost & Sullivan Award Highlights Opportunity for Main Street Biotech
2. Frost & Sullivan Recognizes Life Technologies for Excellence in the Life Science Research Tools Industry
3. Frost & Sullivan Recognizes Excellence in Medical Technologies & Life Sciences
4. Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000
5. Frost & Sullivan: In Vitro Diagnostics Market
6. Frost & Sullivan Recognizes Novagali Pharma for Innovation in Ophthalmic Therapies
7. Frost & Sullivan European Drug Discovery Product Innovation Award Bestowed on Xenometrix AG
8. Frost & Sullivan Recognizes ApaTechs Leadership in Orthopedic Biologics
9. The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan
10. Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning
11. Frost & Sullivan to Present the 2009 Excellence in Medical Technologies & Life Sciences Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... York, NY (PRWEB) , ... April 19, 2017 ... ... to combat Clostridium difficile (C. diff) infections through education and advocacy. Founded ... her life to a C. diff infection, the foundation has become the most-consulted ...
(Date:4/19/2017)... and PUNE, India , April 19, 2017 /PRNewswire/ ... "Membrane Microfiltration Market: Global Opportunity Analysis and Industry Forecast, 2014-2022 ," the global ... $12,858 million by 2022, registering a CAGR of 9.6% from 2016 to 2022. ... ... ...
(Date:4/19/2017)... WESTMINSTER, Colo. , April 19, 2017 ... specialty finance firm that provides senior debt to ... the closing of a $20 million senior secured ... orthobiologics company engaged in the development and commercialization ... of orthopedic injuries. Cerapedics, lead product, ...
(Date:4/19/2017)...   Thermo Fisher Scientific Inc . today ... SEpsis (MOSES) Study have been published in the ... Medicine . Researchers from the study, titled "Serial ... From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study," ... assay to assess risk for 28 day all-cause ...
Breaking Biology Technology:
(Date:4/5/2017)... SEATTLE , April 5, 2017  The Allen ... the Allen Cell Explorer: a one-of-a-kind portal and dynamic ... large-scale 3D imaging data, the first application of deep ... edited human stem cell lines and a growing suite ... the platform for these and future publicly available resources ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
Breaking Biology News(10 mins):